Cue Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $32.2M
Liabilities Breakdown FY2024
Total Liabilities: $14.7M
Asset Breakdown
Total Assets: $32.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $22.5M | 69.8% |
| Accounts Receivable | $945.0K | 2.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $471.0K | 1.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.3M | 25.8% |
Liabilities Breakdown
Total Liabilities: $14.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.8M | 19.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $11.9M | 80.8% |